A Systematic Review on the Impact of Genetic Testing for Familial Melanoma I: Primary and Secondary Preventative Behaviours
Increasing availability of panel testing for known high-penetrance familial melanoma genes has made it possible to improve risk awareness in those at greatest risk. Prior to wider implementation, the role of genetic testing in preventing melanoma, through influencing primary and secondary preventati...
Saved in:
| Published in: | Dermatology (Basel) Vol. 237; no. 5; p. 806 |
|---|---|
| Main Authors: | , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Switzerland
01.01.2021
|
| Subjects: | |
| ISSN: | 1421-9832, 1421-9832 |
| Online Access: | Get more information |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Increasing availability of panel testing for known high-penetrance familial melanoma genes has made it possible to improve risk awareness in those at greatest risk. Prior to wider implementation, the role of genetic testing in preventing melanoma, through influencing primary and secondary preventative behaviours, requires clarification.
Database searches of PubMed, Embase, CINAHL, PsycINFO and the Cochrane Library were conducted for studies describing preventative behaviour outcomes in response to genetic testing for melanoma risk. Publications describing original research of any study type were screened for eligibility.
Eighteen publications describing 11 unique studies were reviewed. Outcomes assessed are based on health behaviour recommendations for those at increased risk: adherence to sun-protective behaviour (SPB); clinical skin examinations (CSE); skin self-examinations (SSE); and family discussion of risk. Overall, modest increases in adherence to primary prevention strategies of SPB were observed following genetic testing. Importantly, there were no net decreases in SPB found amongst non-carriers. For secondary preventative behaviour outcomes, including CSE and SSE, increases in post-test intentions and long-term adherence were reported across several subgroups in approximately half of the studies. While this increase reached significance in mutation carriers in some studies, one study reported a significant decline in annual CSE adherence of non-mutation carriers.
Evidence reviewed suggests that genetic testing has a modestly positive impact on preventative behaviour in high-risk individuals. Furthermore, improvements are observed regardless of mutation carrier status, although greater adherence is found in carriers. While additional studies of more diverse cohorts would be needed to inform clinical recommendations, the findings are encouraging and suggest that genetic testing for melanoma has a positive impact on preventative behaviours. |
|---|---|
| AbstractList | Increasing availability of panel testing for known high-penetrance familial melanoma genes has made it possible to improve risk awareness in those at greatest risk. Prior to wider implementation, the role of genetic testing in preventing melanoma, through influencing primary and secondary preventative behaviours, requires clarification.BACKGROUNDIncreasing availability of panel testing for known high-penetrance familial melanoma genes has made it possible to improve risk awareness in those at greatest risk. Prior to wider implementation, the role of genetic testing in preventing melanoma, through influencing primary and secondary preventative behaviours, requires clarification.Database searches of PubMed, Embase, CINAHL, PsycINFO and the Cochrane Library were conducted for studies describing preventative behaviour outcomes in response to genetic testing for melanoma risk. Publications describing original research of any study type were screened for eligibility.METHODSDatabase searches of PubMed, Embase, CINAHL, PsycINFO and the Cochrane Library were conducted for studies describing preventative behaviour outcomes in response to genetic testing for melanoma risk. Publications describing original research of any study type were screened for eligibility.Eighteen publications describing 11 unique studies were reviewed. Outcomes assessed are based on health behaviour recommendations for those at increased risk: adherence to sun-protective behaviour (SPB); clinical skin examinations (CSE); skin self-examinations (SSE); and family discussion of risk. Overall, modest increases in adherence to primary prevention strategies of SPB were observed following genetic testing. Importantly, there were no net decreases in SPB found amongst non-carriers. For secondary preventative behaviour outcomes, including CSE and SSE, increases in post-test intentions and long-term adherence were reported across several subgroups in approximately half of the studies. While this increase reached significance in mutation carriers in some studies, one study reported a significant decline in annual CSE adherence of non-mutation carriers.RESULTSEighteen publications describing 11 unique studies were reviewed. Outcomes assessed are based on health behaviour recommendations for those at increased risk: adherence to sun-protective behaviour (SPB); clinical skin examinations (CSE); skin self-examinations (SSE); and family discussion of risk. Overall, modest increases in adherence to primary prevention strategies of SPB were observed following genetic testing. Importantly, there were no net decreases in SPB found amongst non-carriers. For secondary preventative behaviour outcomes, including CSE and SSE, increases in post-test intentions and long-term adherence were reported across several subgroups in approximately half of the studies. While this increase reached significance in mutation carriers in some studies, one study reported a significant decline in annual CSE adherence of non-mutation carriers.Evidence reviewed suggests that genetic testing has a modestly positive impact on preventative behaviour in high-risk individuals. Furthermore, improvements are observed regardless of mutation carrier status, although greater adherence is found in carriers. While additional studies of more diverse cohorts would be needed to inform clinical recommendations, the findings are encouraging and suggest that genetic testing for melanoma has a positive impact on preventative behaviours.CONCLUSIONSEvidence reviewed suggests that genetic testing has a modestly positive impact on preventative behaviour in high-risk individuals. Furthermore, improvements are observed regardless of mutation carrier status, although greater adherence is found in carriers. While additional studies of more diverse cohorts would be needed to inform clinical recommendations, the findings are encouraging and suggest that genetic testing for melanoma has a positive impact on preventative behaviours. Increasing availability of panel testing for known high-penetrance familial melanoma genes has made it possible to improve risk awareness in those at greatest risk. Prior to wider implementation, the role of genetic testing in preventing melanoma, through influencing primary and secondary preventative behaviours, requires clarification. Database searches of PubMed, Embase, CINAHL, PsycINFO and the Cochrane Library were conducted for studies describing preventative behaviour outcomes in response to genetic testing for melanoma risk. Publications describing original research of any study type were screened for eligibility. Eighteen publications describing 11 unique studies were reviewed. Outcomes assessed are based on health behaviour recommendations for those at increased risk: adherence to sun-protective behaviour (SPB); clinical skin examinations (CSE); skin self-examinations (SSE); and family discussion of risk. Overall, modest increases in adherence to primary prevention strategies of SPB were observed following genetic testing. Importantly, there were no net decreases in SPB found amongst non-carriers. For secondary preventative behaviour outcomes, including CSE and SSE, increases in post-test intentions and long-term adherence were reported across several subgroups in approximately half of the studies. While this increase reached significance in mutation carriers in some studies, one study reported a significant decline in annual CSE adherence of non-mutation carriers. Evidence reviewed suggests that genetic testing has a modestly positive impact on preventative behaviour in high-risk individuals. Furthermore, improvements are observed regardless of mutation carrier status, although greater adherence is found in carriers. While additional studies of more diverse cohorts would be needed to inform clinical recommendations, the findings are encouraging and suggest that genetic testing for melanoma has a positive impact on preventative behaviours. |
| Author | McInerney-Leo, Aideen M Finnane, Anna Yanes, Tatiane Primiero, Clare A Soyer, H Peter |
| Author_xml | – sequence: 1 givenname: Clare A surname: Primiero fullname: Primiero, Clare A organization: The University of Queensland Diamantina Institute, The University of Queensland, Dermatology Research Centre, Brisbane, Queensland, Australia – sequence: 2 givenname: Tatiane surname: Yanes fullname: Yanes, Tatiane organization: The University of Queensland Diamantina Institute, The University of Queensland, Dermatology Research Centre, Brisbane, Queensland, Australia – sequence: 3 givenname: Anna surname: Finnane fullname: Finnane, Anna organization: School of Public Health, The University of Queensland, Brisbane, Queensland, Australia – sequence: 4 givenname: H Peter surname: Soyer fullname: Soyer, H Peter email: p.soyer@uq.edu.au, p.soyer@uq.edu.au organization: Department of Dermatology, Princess Alexandra Hospital, Brisbane, Queensland, Australia, p.soyer@uq.edu.au – sequence: 5 givenname: Aideen M surname: McInerney-Leo fullname: McInerney-Leo, Aideen M organization: The University of Queensland Diamantina Institute, The University of Queensland, Dermatology Research Centre, Brisbane, Queensland, Australia |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33588421$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkMtOwzAQRS1URB-w4AeQl2wCfqWJ2ZWKlkpFVLSsI8ee0KDELnESVPHzpGqRWM2M7tHMvTNEPessIHRNyR2lobwnhISUSyrP0IAKRgMZc9b71_fR0PvPDmNxJC9Qn_MwjjtxgH4meL33NZSqzjV-gzaHb-wsrreAF-VO6Rq7DM_BwkHfgK9z-4EzV-GZKvMiVwV-gUJZVyq8eMCrKi9VtcfKGrwG7aw5TKsKWrB1d6IF_Ahb1eauqfwlOs9U4eHqVEfoffa0mT4Hy9f5YjpZBpqPZR2MdRozKYRJTUY1NzSNVEbGJBUx4UaElIWEQqzSLAs1VyANG_NIERpFQkkj2QjdHvfuKvfVdBGSMvcais42uMYnTEhCaRxx0aE3J7RJSzDJ7pgn-XsY-wUyoG4I |
| CitedBy_id | crossref_primary_10_1371_journal_pone_0275926 crossref_primary_10_3389_fpubh_2024_1335894 crossref_primary_10_1016_j_ad_2022_04_015 crossref_primary_10_3389_fmed_2021_818096 crossref_primary_10_3389_fgene_2022_919134 crossref_primary_10_1016_j_ad_2022_04_018 |
| ContentType | Journal Article |
| Copyright | 2021 S. Karger AG, Basel. |
| Copyright_xml | – notice: 2021 S. Karger AG, Basel. |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1159/000513919 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1421-9832 |
| ExternalDocumentID | 33588421 |
| Genre | Systematic Review Journal Article |
| GroupedDBID | --- .55 .GJ 0R~ 0~5 0~B 1CY 29F 30W 328 34G 36B 39C 3O- 3O. 4.4 53G 5GY 5RE 7RV 7X7 88E 8AO 8FI 8FJ 8FW 8G5 8UI AAWTL AAYIC ABBTS ABJNI ABPAZ ABUWG ABWCG ACGFS ACPRK ACPSR ACQXL ADAGL ADBBV AENEX AEYAO AFDXO AFFNX AFJJK AFKRA AFRAH AFSIO AHFRZ AHMBA ALDHI ALIPV ALMA_UNASSIGNED_HOLDINGS AZPMC AZQEC BENPR BKEYQ BPHCQ BVXVI CAG CCPQU CGR COF CS3 CUY CVF CYUIP DU5 DWQXO E0A EBS ECM EIF EJD EMB EMOBN EX3 F5P FB. FYUFA GNUQQ GUQSH HMCUK HZ~ IY7 KUZGX L7B M1P M2O N9A NAPCQ NPM O1H O9- P2P PHGZT PQQKQ PROAC PSQYO RIG RKO RXVBD SV3 UJ6 UKHRP WOW X7M ZGI ZXP 7X8 |
| ID | FETCH-LOGICAL-c369t-6cb82944dbdf1c3d1b7af060b4803d4512501e8abff5c3ae9d2637a01774a9d92 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 6 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000619107400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1421-9832 |
| IngestDate | Mon Aug 25 04:32:06 EDT 2025 Thu Apr 03 07:05:50 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Keywords | Genetic testing Preventative behaviour Surveillance Melanoma |
| Language | English |
| License | 2021 S. Karger AG, Basel. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c369t-6cb82944dbdf1c3d1b7af060b4803d4512501e8abff5c3ae9d2637a01774a9d92 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
| OpenAccessLink | https://www.karger.com/Article/Pdf/513919 |
| PMID | 33588421 |
| PQID | 2490118734 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2490118734 pubmed_primary_33588421 |
| PublicationCentury | 2000 |
| PublicationDate | 2021-01-01 |
| PublicationDateYYYYMMDD | 2021-01-01 |
| PublicationDate_xml | – month: 01 year: 2021 text: 2021-01-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Switzerland |
| PublicationPlace_xml | – name: Switzerland |
| PublicationTitle | Dermatology (Basel) |
| PublicationTitleAlternate | Dermatology |
| PublicationYear | 2021 |
| SSID | ssj0002879 |
| Score | 2.3233964 |
| SecondaryResourceType | review_article |
| Snippet | Increasing availability of panel testing for known high-penetrance familial melanoma genes has made it possible to improve risk awareness in those at greatest... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 806 |
| SubjectTerms | Genetic Testing Health Behavior Humans Melanoma - diagnosis Melanoma - prevention & control Melanoma - psychology Melanoma, Cutaneous Malignant Patient Compliance Primary Prevention Secondary Prevention Self-Examination Skin Neoplasms - diagnosis Skin Neoplasms - prevention & control Skin Neoplasms - psychology |
| Title | A Systematic Review on the Impact of Genetic Testing for Familial Melanoma I: Primary and Secondary Preventative Behaviours |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/33588421 https://www.proquest.com/docview/2490118734 |
| Volume | 237 |
| WOSCitedRecordID | wos000619107400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1JS8QwFA5uiBf3Zdx4gtdi07RN40VEFAVnGHCUuQ1Jk4ig7WhHL_55X9Lo3ETwUlraQJO8JG_9PkKOY5VYYYSIqKYaDRQTR4LpNOK25DahNhEenf_hlvd6xXAo-sHh1oS0yu890W_Uui6dj_wEzQRPjc3Ss_Fr5FijXHQ1UGjMknmGqoyTaj6cooWjNSB8dZFLQ0DRDchCeIJ7LjtsQX_RLP0Jc7Xy339bJctBt4TzVhjWyIyp1sliN0TPN8jnOdz9ADdDGxWAugLUAeHGV0tCbcEBUbv3A4e_UT0CarXg6TFQUqFrnmVVv0i4OYV-C1QBstJw5-xq7Z4CJpTHE4eAvvj-1myS-6vLwcV1FMgXopLlYhLlpSoSkaZaaUtLpqni0sZ5rNIixslEPSGLqSmksjYrmTRCJznjEhc4T6XQItkic1VdmR0CVqtMFYUuqEPbs6ngMjN4x_HzWKiyQ46-h3WEwu0iFrIy9Xszmg5sh2y3czMat50bMeZqbBO6-4fWe2Qpcbko3nWyT-YtLm1zQBbKj8lT83bopQavvX73C-2izM0 |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Systematic+Review+on+the+Impact+of+Genetic+Testing+for+Familial+Melanoma+I%3A+Primary+and+Secondary+Preventative+Behaviours&rft.jtitle=Dermatology+%28Basel%29&rft.au=Primiero%2C+Clare+A&rft.au=Yanes%2C+Tatiane&rft.au=Finnane%2C+Anna&rft.au=Soyer%2C+H+Peter&rft.date=2021-01-01&rft.issn=1421-9832&rft.eissn=1421-9832&rft.volume=237&rft.issue=5&rft.spage=806&rft_id=info:doi/10.1159%2F000513919&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1421-9832&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1421-9832&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1421-9832&client=summon |